Ravi Sarin
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Ravi Sarin
Earlier roles on record: Board Member at Starling Oncology, Inc. (STLN) until August 31, 2023. Starling Oncology, Inc. reported in an 8-K filed September 1, 2023 that Ravi Sarin resigned as director of the Board, effective August 31, 2023.
“On August 31, 2023, Ravi Sarin, a member of the Board of Directors (the "Board") of The Oncology Institute, Inc. (the "Company"), resigned effective immediately as a director of the Board, including any positions held as a member of any committee of the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2023-08-31
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.